Back to the full story3 sources · Risk of dementia could be halved with use of metformin◆ Analytics
Risk of dementia could be halved with use of metformin
Deterministic text analytics computed across all 3 sources. Frequency, entity overlap, and claim overlap — computed counts only. Nothing is rated true or false.
01
Frequency Analytics
The most common words and exact phrases across every report in this cluster. Computed counts only.
Top words
dementiavaccineriskmetforminshingleslinkedpeopletakinglowerresearchers
Top phrases
shingles vaccinerisk of dementia
02
Entity Overlap
Names detected in the report text: which appear across multiple sources, and which only one source mentions.
Across multiple sources
None mentioned by more than one source.
Unique to one source
- Shingles · ScienceDaily
- Older · ScienceDaily
- Shingrix · ScienceDaily
- Risk · New Scientist
- Taking · New Scientist
03
Claim Overlap
Near-identical sentences found in two or more reports, versus sentences that appear in only one. Text match only — nothing is rated true or false.
Repeated across sources
No sentence appeared in more than one source.
Appears once
- "Older adults who received the Shingrix shingles vaccine were 24% less likely to be diagnosed with dementia over four years in a study of more than 500,000 people." · ScienceDaily
- "Researchers estimate the difference could amount to roughly one dementia case prevented for every 17 people vaccinated." · ScienceDaily
- "Taking metformin, a type 2 diabetes drug, has been linked to a lower risk of dementia over the following decades, but the association isn't conclusive Taking metformin, a type 2 diabetes drug, has been linked to a lower risk of dementia over the following decades, but the association isn't conclusive" · New Scientist